UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas

Oncogene, 2011-09, Vol.30 (35), p.3813-3820

2011

Volltextzugriff (PDF)

Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth

Journal of biomedical nanotechnology, 2016-04, Vol.12 (4), p.811-830

2016

Volltextzugriff (PDF)

PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy

Oncogene, 2010-11, Vol.29 (47), p.6280-6293

2010

Volltextzugriff (PDF)

Self-assembly nanoparticles for the delivery of bisphosphonates into tumors

International journal of pharmaceutics, 2011-01, Vol.403 (1-2), p.292-297

2011

Volltextzugriff (PDF)

Targeted therapy for brain tumours: role of PARP inhibitors

Current cancer drug targets, 2012-03, Vol.12 (3), p.218-236

2012

Volltextzugriff (PDF)

Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy

Journal of clinical oncology, 2003-03, Vol.21 (5), p.927-931

2003

Volltextzugriff (PDF)

Targeting different signaling pathways with antisense oligonucleotides combination for cancer therapy

Current pharmaceutical design, 2007-02, Vol.13 (5), p.463-470

2007

Volltextzugriff (PDF)

Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials

BMJ, 1998-04, Vol.316 (7140), p.1275-1285

International edition, 1998

Volltextzugriff (PDF)

P0310 : FAK/EZH2 functional interaction is crucial for HCC development and progression both in vivo and in vitro

Journal of hepatology, 2015-04, Vol.62, p.S425-S425

2015

Volltextzugriff (PDF)

FAK depletion/inhibition reduces the expression of liver cancer stem cells markers

Digestive and liver disease, 2017-02, Vol.49 (1), p.e48-e48

2017

Volltextzugriff (PDF)

Error Analysis of Frame Reconstruction From Noisy Samples

IEEE transactions on signal processing, 2008-06, Vol.56 (6), p.2311-2325

2008

Volltextzugriff (PDF)

796: The G-quadruplex ligand EMICORON has antitumoral activity against orthotopic and patient-derived human colon cancer xenografts

European journal of cancer (1990), 2014-07, Vol.50, p.S192-S192

2014

Volltextzugriff (PDF)

Evidence for G-quadruplex in the promoter of VEGFR-2 and its targeting to inhibit tumor angiogenesis

Nucleic acids research, 2014-12, Vol.42 (22), p.14083-14083

2014

Volltextzugriff (PDF)

Silencing of the focal adhesion kinase reduces hepatocellular carcinoma growth affecting enhancer of zeste homolog 2 transcription and activity

Digestive and liver disease, 2016-02, Vol.48, p.e14-e14

2016

Volltextzugriff (PDF)

787: Transferrin-conjugated self assembled nanoparticles incorporating ZOL as a tool for the targeting of glioblastoma

European journal of cancer (1990), 2014-07, Vol.50, p.S189-S189

2014

Volltextzugriff (PDF)

Scleroderma-like disorders

Autoimmunity reviews, 2008-02, Vol.7 (4), p.331-339

2008

Volltextzugriff (PDF)

Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent

Current cancer drug targets, 2010-06, Vol.10 (4), p.368-383

2010

Volltextzugriff (PDF)

Che-1 activates XIAP expression in response to DNA damage

Cell death and differentiation, 2008-03, Vol.15 (3), p.515-520

2008

Volltextzugriff (PDF)

In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells

Current cancer drug targets, 2010-09, Vol.10 (6), p.600-610

2010

Volltextzugriff (PDF)

Buschke Scleredema, case report

Reumatismo, 2011-09, Vol.58 (4), p.310-313

2011

Volltextzugriff (PDF)

Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFα treatment

Reumatismo, 2011-09, Vol.59 (2), p.169-172

2011

Volltextzugriff (PDF)

Systemic Administration of GPI 15427, a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, Increases the Antitumor Activity of Temozolomide against Intracranial Melanoma, Glioma, Lymphoma

Clinical cancer research, 2003-11, Vol.9 (14), p.5370-5379

2003

Volltextzugriff (PDF)

Combined therapy with Sorafenib and FAK inhibitor TAE226 impairs hepatocellular carcinoma growth by interfering with epigenetic modifications and stemness markers

Digestive and liver disease, 2019-02, Vol.51, p.e36-e36

2019

Volltextzugriff (PDF)

Nanotechnologies to use zoledronic acid as a potent antitumoral agent

Journal of drug delivery science and technology, 2011, Vol.21 (3), p.283-284

2011

Volltextzugriff (PDF)

1 – 25 von 940

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(702)
Mit Volltextzugriff
(667)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(464)
Ingenta
(400)
Journals@Ovid Full Text
(356)
EZB Electronic Journals Library
(318)
Elsevier ScienceDirect Journals Complete
(220)
IngentaConnect Journals
(186)
Publisher or Other Site
(135)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(101)
Wiley-Blackwell Journals
(71)
Springer journals
(59)
Oxford journals
(52)
Wiley Online Library
(50)
Oxford Journals 2020 Medicine
(47)
Nature Journals Online
(37)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(34)
JSTOR
(30)
SAGE Publications
(22)
Thieme - Connect here FIRST to enable access
(17)
Nexis Uni
(14)
Taylor & Francis Journals
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas

Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth

PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy

Self-assembly nanoparticles for the delivery of bisphosphonates into tumors

Targeted therapy for brain tumours: role of PARP inhibitors

Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy

Targeting different signaling pathways with antisense oligonucleotides combination for cancer therapy

Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials

P0310 : FAK/EZH2 functional interaction is crucial for HCC development and progression both in vivo and in vitro

FAK depletion/inhibition reduces the expression of liver cancer stem cells markers

Error Analysis of Frame Reconstruction From Noisy Samples

796: The G-quadruplex ligand EMICORON has antitumoral activity against orthotopic and patient-derived human colon cancer xenografts

Evidence for G-quadruplex in the promoter of VEGFR-2 and its targeting to inhibit tumor angiogenesis

Silencing of the focal adhesion kinase reduces hepatocellular carcinoma growth affecting enhancer of zeste homolog 2 transcription and activity

787: Transferrin-conjugated self assembled nanoparticles incorporating ZOL as a tool for the targeting of glioblastoma

Scleroderma-like disorders

Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent

Che-1 activates XIAP expression in response to DNA damage

In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells

Buschke Scleredema, case report

Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFα treatment

Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes

Systemic Administration of GPI 15427, a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, Increases the Antitumor Activity of Temozolomide against Intracranial Melanoma, Glioma, Lymphoma

Combined therapy with Sorafenib and FAK inhibitor TAE226 impairs hepatocellular carcinoma growth by interfering with epigenetic modifications and stemness markers

Nanotechnologies to use zoledronic acid as a potent antitumoral agent

Suchergebnisse filtern